AAAAAA
Results:
1-8
|
Results: 8
Authors:
Inoue, K
Wood, CG
Slaton, JW
Karashima, T
Sweeney, P
Dinney, CPN
Citation: K. Inoue et al., Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8, ONCOL REP, 8(5), 2001, pp. 955-964
Authors:
Yang, J
Fizazi, K
Peleg, S
Sikes, CR
Raymond, AK
Jamal, N
Hu, M
Olive, M
Martinez, LA
Wood, CG
Logothetis, CJ
Karsenty, G
Navone, NM
Citation: J. Yang et al., Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway, CANCER RES, 61(14), 2001, pp. 5652-5659
Authors:
Inoue, K
Perrotte, P
Wood, CG
Slaton, JW
Sweeney, P
Dinney, CPN
Citation: K. Inoue et al., Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor, CLIN CANC R, 6(11), 2000, pp. 4422-4431
Authors:
Wood, CG
von Eschenbach, AC
Citation: Cg. Wood et Ac. Von Eschenbach, The clinical problem of prostate cancer, PROG ANTI C, 4, 2000, pp. 203-211
Authors:
Pisters, LL
Pettaway, CA
Hossan, E
Evans, R
Steiner, MS
Wood, CG
Troncoso, P
McDonnell, TJ
Fenstenmacher, MJ
Logothetis, CJ
Citation: Ll. Pisters et al., Intraprostatic AD-p53 gene therapy followed by radical prostatectomy: feasibility and preliminary results, PROSTATE C, 2, 1999, pp. S27-S27
Authors:
Wood, CG
Citation: Cg. Wood, G-rich sequence factor 1, a novel marker of prostate cancer virulence identified through mRNA differential display, PROSTATE C, 2, 1999, pp. S35-S35
Authors:
Luo, WP
Tapolsky, M
Earley, K
Wood, CG
Wilson, DR
Logothetis, CJ
Lin, SH
Citation: Wp. Luo et al., Tumor-suppressive activity of CD66a in prostate cancer, CANC GENE T, 6(4), 1999, pp. 313-321
Authors:
Spencer, TE
Stagg, AG
Joyce, MM
Jenster, G
Wood, CG
Bazer, FW
Wiley, AA
Bartol, FF
Citation: Te. Spencer et al., Discovery and characterization of endometrial epithelial messenger ribonucleic acids using the ovine uterine gland knockout model, ENDOCRINOL, 140(9), 1999, pp. 4070-4080
Risultati:
1-8
|